Drug Company Gift Disclosure Act
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5494-5495)
April 29, 2003
View full timeline
Introduced in Senate
April 29, 2003
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5494-5495)
April 29, 2003
Floor Debate
15 membersWhat members said about S. 948 on the floor




+10
Floor Debate
15 membersWhat members said about S. 948 on the floor
Mr. President, I rise today to introduce, along with Senators Durbin, Reid, and Kerry, the ``Renewable Energy Investment Act of 2003.'' This legislation will guarantee that by the year 2020, twenty…
Mr. President, today, Senator Hagel and I, and others introduce ``The IDEA Full Funding Act of 2003.'' This bill will provide increased mandatory funding for the Individuals with Disabilities…
Mr. President, today, we are introducing the ``Government Settlement Transparency Act of 2003.'' Over the past several months, we have become increasingly concerned about the approval of various…
Mr. President, today I rise to introduce the Fuel Tax Equalization Credit for Substantial Power Takeoff Vehicles Act. This bill upholds a long-held principle in the application of the Federal fuels…
Mr. President, last November, the Drug Competition Act passed the Senate by unanimous consent. This morning, I am proud to join Senator Grassley, along with Senators Durbin, Feingold, Kohl and…
Show 8 more
Mr. President, I am pleased to join Senator Leahy today in introducing the Drug Competition Act of 2003. This bill will help Federal regulators ensure that there is full and unfettered access to…
Mr. President, I rise in support of the IDEA Full Funding Act of 2003. I'm so proud to cosponsor this important legislation. This bill provides mandatory increases for IDEA funding each year, so that…
Mr. President, rural America has been depopulating at an alarming rate. The same is true for the rural counties in Kansas. In fact, over half of the counties in the State are losing population. We…
Mr. President, today I join Senator Brownback in introducing the Rural Community Hospital Assistance Act. This legislation is intended to ensure the future of small rural hospitals by restructuring…
Mr. President, I am proud to sponsor the Military Pay Comparability Act of 2003. In 1999, the Committee on Armed Services passed landmark legislation providing significant benefits to the entire…
Mr. President, today Senator Feinstein and I are introducing the ``Overseas Military Facility Structure Review Act'' to establish a congressional panel to conduct a detailed study of U.S. military…
Mr. President, today I introduce, with Senators Campbell, Domenici, Hatch, Inouye, and Murkowski, the Federal Land Recreational Visitor Protection Act of 2003. Across our State of Alaska, Western…
Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.
Show 3 more
Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.
Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.
Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.
Bill Text
Latest available legislative text
[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 948 Introduced in Senate (IS)]
108th CONGRESS
1st Session
S. 948
To require prescription drug manufacturers, packers, and distributors
to disclose certain gifts provided in connection with detailing,
promotional, or other marketing activities, and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
April 29, 2003
Mr. Schumer introduced the following bill; which was read twice and
referred to the Committee on Health, Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To require prescription drug manufacturers, packers, and distributors
to disclose certain gifts provided in connection with detailing,
promotional, or other marketing activities, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Drug Company Gift Disclosure Act''.
SEC. 2. DISCLOSURE BY PRESCRIPTION DRUG MANUFACTURERS, PACKERS, AND
DISTRIBUTORS OF CERTAIN GIFTS.
Section 503 of the Federal Food, Drug, and Cosmetics Act (21
U.S.C. 353) is amended by adding at the end the following:
``(h)(1) Each manufacturer, packer, or distributor of a drug
subject to subsection (b)(1) shall disclose to the Commissioner--
``(A) not later than June 30, 2004, and each June 30
thereafter, the value, nature, and purpose of any--
``(i) gift provided during the preceding calendar
year to any covered health entity by the manufacturer,
packer, or distributor, or a representative thereof, in
connection with detailing, promotional, or other
marketing activities; and
``(ii) cash rebate, discount, or any other
financial consideration provided during the preceding
calendar year to any pharmaceutical benefit manager by
the manufacturer, packer, or distributor, or a
representative thereof, in connection with detailing,
promotional, or other marketing activities; and
``(B) not later than the date that is 6 months after the
date of enactment of this subsection and each June 30
thereafter, the name and address of the individual responsible
for the compliance of the manufacturer, packer, or distributor
with the provisions of this subsection.
``(2) Subject to paragraph (3), the Commissioner shall make all
information disclosed to the Commissioner under paragraph (1) publicly
available, including by posting such information on the Internet.
``(3) The Commissioner shall keep confidential any information
disclosed to or otherwise obtained by the Commissioner under this
subsection that relates to a trade secret referred to in section 1905
of title 18, United States Code. The Commissioner shall provide an
opportunity in the disclosure form required under paragraph (4) for a
manufacturer, packer, or distributor to identify any such information.
``(4) Each disclosure under this subsection shall be made in such
form and manner as the Commissioner may require.
``(5) Each manufacturer, packer, and distributor described in
paragraph (1) shall be subject to a civil monetary penalty of not more
than $10,000 for each violation of this subsection. Each unlawful
failure to disclose shall constitute a separate violation. The
provisions of paragraphs (3), (4), and (5) of section 303(g) shall
apply to such a violation in the same manner as such provisions apply
to a violation of a requirement of this Act that relates to devices.
``(6) For purposes of this subsection:
``(A) The term `covered health entity' includes any
physician, hospital, nursing home, pharmacist, health benefit
plan administrator, or any other person authorized to prescribe
or dispense drugs that are subject to subsection (b)(1), in the
District of Columbia or any State, commonwealth, possession, or
territory of the United States.
``(B) The term `gift' includes any gift, fee, payment,
subsidy, or other economic benefit with a value of $50 or more,
except that such term excludes the following:
``(i) Free samples of drugs subject to subsection
(b)(1) intended to be distributed to patients.
``(ii) The payment of reasonable compensation and
reimbursement of expenses in connection with any bona
fide clinical trial conducted in connection with a
research study designed to answer specific questions
about drugs, devices, new therapies, or new ways of
using known treatments.
``(iii) Any scholarship or other support for
medical students, residents, or fellows selected by a
national, regional, or specialty medical or other
professional association to attend a significant
educational, scientific, or policy-making conference of
the association.''.
<all>